Rigel Pharmaceuticals, Inc. (RIGL)
NASDAQ: RIGL · Real-Time Price · USD
38.72
0.00 (0.00%)
At close: Jul 2, 2026, 4:00 PM EDT
40.67
+1.95 (5.03%)
Pre-market: Jul 6, 2026, 7:05 AM EDT
Rigel Pharmaceuticals Employees
As of December 31, 2025, Rigel Pharmaceuticals had 174 total employees, including 172 full-time and 2 part-time employees. The number of employees increased by 10 or 6.10% compared to the previous year.
Employees
174
Change (1Y)
10
Growth (1Y)
6.10%
Revenue / Employee
$1,722,799
Profits / Employee
$2,093,287
Market Cap
716.40M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 174 | 10 | 6.10% | 172 | 2 |
| Dec 31, 2024 | 164 | 17 | 11.56% | 162 | 2 |
| Dec 31, 2023 | 147 | -8 | -5.16% | 147 | 0 |
| Dec 31, 2022 | 155 | -10 | -6.06% | 155 | 0 |
| Dec 31, 2021 | 165 | -4 | -2.37% | 165 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Ginkgo Bioworks Holdings | 485 |
| REGENXBIO | 371 |
| 4D Molecular Therapeutics | 196 |
| CorMedix | 191 |
| Allogene Therapeutics | 152 |
| Prime Medicine | 146 |
| Tectonic Therapeutic | 60 |
| Candel Therapeutics | 55 |
RIGL News
- 4 days ago - Rigel appoints Alison Hannah as Chief Medical Officer and Vice President - TheFly
- 4 days ago - Rigel Appoints Board Member Alison L. Hannah, M.D. - PRNewsWire
- 19 days ago - Rigel closes license agreement for Veppanu - TheFly
- 19 days ago - Rigel Announces Closing of Licensing Agreement for VEPPANU™ (vepdegestrant) - PRNewsWire
- 20 days ago - Rigel Pharmaceuticals Slides: Corporate presentation - Filings
- 4 weeks ago - Rigel Pharmaceuticals Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 5 weeks ago - Rigel to Present at the Jefferies Global Healthcare Conference - PRNewsWire
- 6 weeks ago - Rigel Announces Oral and Poster Presentations at the 2026 ASCO Annual Meeting and EHA2026 Congress - PRNewsWire